TOKYO, Jan 25 (Reuters) - Permira [PERM.UL], CVC Capital Partners [CVC.UL], Advantage Partners and Goldman Sachs GS.N are considering submitting bids to buy Japanese food supplement maker Everlife from CLSA Capital Partners, five people familiar with the transaction said.
CLSA Capital Partners, a private equity arm of Credit Agricole SA CAGR.PA, has started a sale process and the first round of bids will be closed on Jan. 31, the people said.
The deal could be worth 50 billion to 70 billion yen ($606-848 million), they added. [ID:nTOE6AI046]
The people spoke on condition of anonymity because the process is not public.
CLSA Capital Partners, Permira, CVC Capital, Goldman Sachs and Advantage Partners declined to comment.
Bank of America Merrill Lynch BAC.N is advising CLSA Capital on the sale. ($1=82.52 Yen) (Reporting by Junko Fujita; Editing by Edmund Klamann)
Our Standards: The Thomson Reuters Trust Principles.